Safety issues with an infusion pump and soft demand for IV fluid after the shortage are eating into the company's bottom line ...

| Baxter Healthcare is pleased to share the growing success of the room temperature storage configuration of Hemopatch Sealing Hemostat, launched earlier, this Summer, across Australia and New Zealand ...

Patel discusses the healthcare company's transformation and the work of IT to achieve the organization’s goals.

Healthcare company Baxter International (NYSE:BAX) in Q3 CY2025, but sales rose 5% year on year to $2.84 billion. Next ...

Baxter’s Q3 profit rose 41% year-over-year, but gross margin plunged 430 basis points to 39.4% amid higher manufacturing ...

Shares of healthcare company Baxter International (NYSE:BAX) fell 13.5% in the morning session after the company reported ...

Baxter International stock hits 20-year low, but undervaluation and new CEO strategy offer turnaround potential.

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter anticipates a full-year 2025 adjusted operating margin of approximately 16.5% on a continuing operations basis. Baxter sales grew 4% on both a reported and constant currency basis, inline with ...

The storm tested every system and every person—revealing the true power of maintenance and reliability leadership under ...

The program includes student field trips to Northwestern's Feinberg School of Medicine and mentoring with undergraduates ...

Shares of healthcare company Baxter International (NYSE:BAX) fell 2.9% in the afternoon session after the stock continued to ...